(August 17, 2023, 2:54 PM EDT) -- NEWARK, N.J. — A federal judge in New Jersey granted class certification for investors who bought shares of a medical device maker they allege concealed defects with its infusion pump product, made changes to it without Food and Drug Administration approval and made misleading statements to investors, finding that the investors met the Federal Rules of Civil Procedure requirements for class certification....